Civica Partners With Phlow To Build $125m Injectables Facility In US

Operations Expected To Begin Within Three Years

Strategy
Building US manufacturing space has been a part of Civica’s supply strategy since it was founded in 2018 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business